Product image of Hytrin (Terazosin) supplied by GNH India

Hytrin

Active Ingredient:
Terazosin
Origin:
EU

Hytrin (Terazosin)

Terazosin, the active ingredient in Hytrin, is a alpha-1 adrenergic receptor antagonist presented as a tablet for oral use. It treats hypertension and benign prostatic hyperplasia in adult patients.
GNH India supplies Hytrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Amdipharm Uk Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Terazosin is used to manage conditions that involve vascular tone and smooth‑muscle tone in the prostate.
  • Hypertension: lowers systemic blood pressure by relaxing arterial smooth muscle.
  • Benign prostatic hyperplasia: improves urinary flow by relaxing prostate and bladder neck smooth muscle.

How It Works

  • Terazosin selectively blocks alpha‑1 adrenergic receptors on vascular smooth muscle and in the prostate. This blockade prevents norepinephrine‑mediated contraction, leading to vasodilation and reduced peripheral resistance, as well as relaxation of prostatic and bladder neck smooth muscle, facilitating urine passage.

Side Effects

Terazosin may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

  • Dizziness or light‑headedness, especially after the first dose.
  • Headache.
  • Fatigue or general weakness.
  • Nasal congestion or runny nose.
  • Peripheral edema.
  • Nausea or mild gastrointestinal upset.

Serious or Rare Side Effects

  • Marked hypotension or syncope.
  • Priapism (prolonged erection).
  • Severe allergic reactions such as rash, itching, or swelling.
  • Liver function abnormalities.
  • Worsening heart failure.
  • Rapid or irregular heartbeat.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

  • Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension.
  • Renal and hepatic function: assess before starting and adjust if impairment is present.
  • Orthostatic changes: advise patients to rise slowly to reduce dizziness.
  • Concomitant antihypertensives: review for additive blood‑pressure‑lowering effects.
  • History of orthostatic hypotension: use with caution.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Terazosin can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Other alpha‑blockers (e.g., prazosin, doxazosin) – risk of profound hypotension.
  • Potent CYP3A4 inhibitors (e.g., ketoconazole) – increased terazosin plasma levels.
  • Phosphodiesterase‑5 inhibitors (e.g., sildenafil) – additive vasodilatory effect.
  • Lithium – possible increase in lithium concentrations.
  • Strong antihypertensive combinations – may cause excessive blood‑pressure drop.

Moderate Interactions (Monitor Closely)

  • Diuretics – may enhance orthostatic hypotension.
  • NSAIDs – can blunt antihypertensive response.
  • Tricyclic antidepressants – may increase risk of dizziness.
  • Beta‑blockers – additive heart‑rate lowering effect.
  • Calcium channel blockers – monitor for combined blood‑pressure effects.

Frequently Asked Questions

Hytrin, whose active ingredient is terazosin, is prescribed for managing high blood pressure (hypertension) and for relieving urinary symptoms associated with benign prostatic hyperplasia (BPH). It works by relaxing blood vessels and prostate smooth muscle, helping to lower blood pressure and improve urine flow.

Terazosin selectively blocks alpha‑1 adrenergic receptors located on vascular smooth muscle and in the prostate. By preventing norepinephrine from activating these receptors, the drug causes blood vessels to dilate, reducing peripheral resistance, and relaxes the prostate and bladder neck, easing urinary obstruction.

The appropriate dose of Hytrin is determined by the prescribing clinician based on the individual’s medical condition, response, and tolerance. Dosage may be started low and titrated upward, but exact strength and schedule should follow the healthcare provider’s instructions.

Safety data for terazosin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare professional.

To request Hytrin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and import documentation.

Hytrin (terazosin) shares the same class mechanism as other alpha‑1 blockers such as prazosin and doxazosin. Compared with some alternatives, terazosin often has a longer half‑life, allowing once‑daily dosing, and may have a slightly different side‑effect profile, but efficacy for hypertension and BPH is comparable.

Hytrin tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children.

Hytrin is taken orally, usually with a full glass of water. It can be taken with or without food, but patients are advised to follow the specific instructions provided by their prescriber to ensure optimal absorption and minimize side effects.

The most serious risks include severe hypotension, syncope, priapism, and rare allergic reactions such as rash or swelling. Patients should seek immediate medical attention if they experience sudden dizziness, fainting, a painful prolonged erection, or signs of an allergic response.

Hytrin is contraindicated in patients with known hypersensitivity to terazosin or any component of the formulation. Caution is advised for individuals with severe orthostatic hypotension, recent myocardial infarction, or those taking certain interacting medications; these patients should discuss alternatives with their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Terazosin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT